Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus

被引：0

作者：

Lu QiLin ^{[1
,2
,3
,4
,5
,6
]}

Wang XiaoZhen ^{[1
,2
,3
,4
,5
,6
]}

Xie Wei ^{[1
,2
,3
,4
,5
,6
]}

Chen XiongWei ^{[1
,2
,3
,4
,5
,6
]}

Zhu YiLiang ^{[1
,2
,3
,4
,5
,6
]}

Li XuGui

机构：

[1] ChinaDepartmentofOrthopedics

[2] DepartmentofOrthopedics

[3] Hubei430065

[4] Hubei672OrthopaedicsHospitalofIntegratedChinese&WesternMedicine

[5] HubeiUniversityofChineseMedicine

[6] Wuhan

来源：

中华医学杂志英文版 | 2020年 / 133卷 / 05期

关键词：

D O I：

暂无

中图分类号：

+ [];

学科分类号：

摘要：

<正>To the Editor: Lumbar spinal canal stenosis (LSCS) is a common disease among older individuals. Hypertrophic lumbar ligamentum flavum (LLF) plays a vital role in the pathogenesis of LSCS. The physiolo

引用

页码：623 / 624-625

共 50 条

[31] Inhibition of Macrophage Migration Inhibitory Factor Reduces Diabetic Nephropathy in Type II Diabetes Mice
Zhigang Wang
Meng Wei
Meng Wang
Lei Chen
Hua Liu
Yi Ren
Kehui Shi
Hongli Jiang
Inflammation, 2014, 37 : 2020 - 2029
[32] Inhibition of Macrophage Migration Inhibitory Factor Reduces Diabetic Nephropathy in Type II Diabetes Mice
Wang, Zhigang
Wei, Meng
Wang, Meng
Chen, Lei
Liu, Hua
Ren, Yi
Shi, Kehui
Jiang, Hongli
INFLAMMATION, 2014, 37 (06) : 2020 - 2029
[33] Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes
Ismail, Nagwa Abdallah
Abd El Baky, Abeer N.
Ragab, Shadia
Hamed, Mona
Hashish, Maha Abo
Shehata, Abed
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (06): : 641 - 645
[34] Role of Macrophage in Type 2 Diabetes Mellitus: Macrophage Polarization a New Paradigm for Treatment of Type 2 Diabetes Mellitus
Banu, Sarmin
Sur, Debjeet
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (01) : 2 - 11
[35] Does macrophage migration inhibitory factor precipitates obesity-associated type 2 diabetes development - an animal study
Cvjeticanin, T.
Stosic-Grujicic, S.
Stojanovic, I.
DIABETOLOGIA, 2008, 51 : S331 - S331
[36] Macrophage Migration Inhibitory Factor-A Potential Target for Diabetes Prevention?
Mokshagundam, Sri Prakash L.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 355 (06): : 519 - 520
[37] Macrophage migration inhibitory factor and its relationship with obesity and diabetes.
Matia-Garcia, Ines
de la Cruz-Mosso, Ulises
Francisco Munoz-Valle, Jose
Parra-Rojas, Isela
INVESTIGACION CLINICA, 2014, 55 (03): : 266 - 277
[38] Increase of macrophage migration inhibitory factor (MIF) expression in human malignant glioma may contribute to immune escape and proliferation.
Mittelbronn, M
Meyermann, R
Weller, M
Wischhusen, J
ACTA NEUROPATHOLOGICA, 2005, 110 (03) : 334 - 334
[39] Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy
Koga, Kiyokazu
Kenessey, Agnes
Ojamaa, Kaie
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 304 (02): : H282 - H293
[40] Increased macrophage migration inhibitory factor (MIF) expression in non hypertention and cardiovascular disease 2 type diabetes patients with LVDD
Chen, Hong-Mei
Lin, Qiu-Xiong
Yang, HuaZhang
Xu, Yan
Tan, Hong-Hong
Yu, XiYong
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 303 - 303

← 1 2 3 4 5 →